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hold the T cell receptor in clusters at the cell surface
where they can be visualized. One hypothesis tested is
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marker was highly mobile, suggesting that it was not
Kenworthy, A.K., and Edidin, M. (1998). J. Cell Biol. 142, 69–84.
confined to a lipid-based microdomain and presumably
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highly mobile, lateral mobility measurements of Lck and
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LAT showed that these molecules could undergo an Struct. 33, 269–295.
abrupt transition from a highly mobile to a highly immo- Zhang, W., Trible, R.P., and Samelson, L.E. (1998). Immunity 9,
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of Lck and LAT to interact with other proteins. Because
of these observations, they proposed that highly mobile
signaling molecules diffusing in the plasma membrane
randomly encounter activated signaling complexes.
When the proper protein-protein interaction domain is
present, this encounter results in the capture of the sig-
naling molecule by the nascent signaling complex.
Photobleaching experiments further supported their
idea that signaling clusters were not fixed but rather
constantly exchanging molecules, presumably through
the formation and dissociation of protein-protein in-
teractions. This exchange of molecules into and out of
signaling clusters was observed directly using dual-
color imaging where the trajectory of a single GFP-
tagged protein could be imaged relative to a more im-
mobile signaling cluster marked with RFP. Using this
approach, Douglass and Vale found that immobilization
of a single molecule occurred more frequently when it
spatially overlapped with a signaling cluster; however,
this immobilization was generally transient. Upon leav-
ing the signaling cluster, the molecule could return to a
highly mobile state rapidly diffusing into other areas of
the plasma membrane. Thus, Douglass and Vale were
able to visualize for the first time the assembly of sig-
naling complexes mediated by the stimulation through
the T cell receptor.
This study by Douglass and Vale challenges many of
our assumptions and models regarding plasma-mem-
brane microdomains and their role in T cell signaling.
While these results suggest that detergent insolubility
does not serve as the organizing principle for the as-
sembly of signaling complexes at the plasma mem-
brane, they also do not invalidate the existence of lipid
rafts or their participation in T cell signaling. The results
obtained here are compatible with the idea that lipid
rafts are either extremely small and highly dynamic or
that they constitute a significant proportion of the
plasma membrane. Hopefully, the implications of this
paradigm shift will begin to shed light upon the role
these plasma-membrane microdomains play in mediat-
ing signals downstream of the TCR.DOI 10.1016/j.cell.2005.06.001
Anchors Away!
Fos Fosters Anchor-Cell Invasion
Invasion of cells through breakdown of the basement
membrane is a crucial step during development and
cancer metastasis. In this issue of Cell, Sherwood et
al., (2005) describe a simple and genetically tractable
cellular assay in the worm for elucidating the molecu-
lar processes that underlie cell invasion in vivo. They
demonstrate that the transcription factor Fos is re-
quired for cell invasion and identify three of its down-
stream target genes (encoding a matrix metalloprotei-
nase, hemicentin, and a fat-like protocadherin).
Tumor metastasis is an enormously complex phenome-
non of critical biomedical importance. For tumors to
form metastases, one of the first things the tumor cells
must do is to break away from the tissue of origin and
invade neighboring localities. Similar cell-invasion be-
haviors are a part of normal development in many or-
ganisms. In their new study, Sherwood et al., (2005)
characterize a normal cell-invasion event in the worm
Caenorhabditis elegans that is elegant in its simplicity,
beautiful in the clarity with which it can be studied, and
amenable to genetic analysis. With this cellular assay,
they demonstrate a key role for the transcription factor
Fos in cell invasion and identify three of its downstream
target genes. In addition, the authors test the functional
contributions of these target genes to cell invasion indi-
vidually and in combination and arrive at results that
one would not have entirely predicted.
In previous work, these authors described how a sin-
gle cell in C. elegans, called the anchor cell, invades
Previews
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(Sherwood and Sternberg, 2003). They found that spe-
cific ventral uterine precursor cells that develop directly
beneath the anchor cell secrete an as-yet-unidentified
chemoattractant. In response to this chemoattractant,
the anchor cell extends a protrusion, which degrades
the basement membrane precisely in between the an-
chor cell and the ventral uterine precursors. Thus, the
anchor cell is able to move down in between the ventral
uterine precursor cells leading to formation of the vulva.
In their new study, Sherwood et al. (2005) describe
how the transcription factor Fos and three of its target
genes promote anchor-cell invasion during C. elegans
development. The authors demonstrate that a mutation
causing a premature stop codon in one of two alterna-
tive transcripts from the fos gene causes a failure of
anchor-cell invasion. The phenotype can be rescued by
expression of the affected transcript and protein in the
anchor cell. The Fos-1a transcript and protein are nor-
mally expressed at highest levels in the anchor cell,
whereas the alternative Fos product is more widely ex-
pressed. The authors show convincingly that the an-
chor cell of fos-1a worm mutants is still able to extend a
cellular protrusion toward the ventral uterine precursor
cells but that the defect lies in the basement mem-
brane, which remains intact.
Isoforms of worm Fos belong to an evolutionarily
conserved family of transcriptional regulators that con-
tain a basic region-leucine zipper (bZIP; Chinenov and
Kerppola, 2001). Fos was originally identified as the
product of a viral oncogene that causes osteosarcoma
in the mouse. Its normal cellular counterpart, c-fos, can
be induced in response to a variety of extracellular
stimuli. There are four normal cellular Fos proteins in
mammals: Fos, FosB, Fra-1, and Fra-2. Fos proteins
form heterodimers with Jun and bind to AP-1 sites in
the promoters of target genes. But they can also asso-
ciate with numerous other bZIP transcription factors in
a variety of different complexes.
The finding that Fos is important in anchor-cell inva-
sion in the worm validates this system as a general
model because Fos has also been implicated in several
types of cell invasion in mammals. For example, Fos
and Jun are expressed at the appropriate time and
place in mammalian trophoblast cells to stimulate tro-
phoblast invasion during development of the placenta
(Bischof, 2001). In addition, Fos-transformed rat fibro-
blasts are highly invasive (Reichmann et al., 1992). Fos
also appears to contribute to tumor metastasis in at
least some types of cancer. For example, c-fos defi-
ciency prevents the progression to malignancy of be-
nign papillomas in a mouse model of skin cancer (Saez
et al., 1995). In addition, expression of c-fos correlates
with poor prognosis in squamous-cell lung carcinomas
(Volm et al., 1993), and c-fos is expressed at a higher
level in malignant prostate cancer than in benign pros-
tatic hyperplasia (Aoyagi et al., 1998). Thus, Fos is likely
to contribute to cell invasion during both normal devel-
opment and pathological processes. The new work by
Sherwood et al., (2005), however, demonstrates this in
vivo with unprecedented single-cell resolution and
crystal clarity.
These authors also identified three likely downstream
targets of Fos in the anchor cell of C. elegans. In so
doing, they reveal some expected results as well assome surprises. They identified the three target genes
as zmp-1, him-4, and cdh-3. The zmp-1 gene encodes
a matrix metalloprotease. him-4 encodes hemicentin,
which is a fibulin-like matrix component that accumu-
lates specifically under the anchor cell. The cdh-3 gene
encodes a Fat-like protocadherin. Individually, muta-
tions affecting zmp-1 or cdh-3 cause little discernible
effect on anchor-cell invasion, whereas mutations in
him-4 cause delayed anchor-cell invasion in a small
percentage of animals. However, when all three genes
carry mutations, the phenotype is more severe than
that seen in the him-4 single mutant.
The identification of downstream targets of Fos in the
anchor cell, together with the ability to test the func-
tions of these target genes, both individually and in
combination, demonstrate how the anchor-cell invasion
assay extends our understanding of the role of Fos and
its targets during cell invasion. Surprisingly, whereas
matrix metalloproteases have been implicated as key
targets of Fos during cell invasion in other systems,
during anchor-cell invasion in the worm, matrix metallo-
proteases play at best a subtle role in degrading the
basement membrane. In contrast, hemicentin, a mem-
ber of the fibulin family, which is thought to organize
the extracellular matrix and stabilize cell adhesion, con-
tributes more significantly to promoting anchor-cell in-
vasion. Many questions remain to be answered. What
is the nature of the chemoattractant that initiates an-
chor-cell invasion? What controls the protrusive activity
of the anchor cell? How, precisely, does hemicentin
promote anchor-cell invasion? Does Fos-1a form di-
mers with the C. elegans Jun homolog in the anchor
cell? What other Fos target genes contribute to anchor-
cell invasion? Perhaps the identification of additional
Fos targets in the worm anchor cell will shed light on
target genes switched on by Fos in trophoblasts during
placental development and in metastatic tumor cells.
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